Rheumatology
201 – 210 of 1643
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus : data from the COVID-19 Global Rheumatology Alliance
- Contribution to journal › Article
-
Mark
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
- Contribution to journal › Article
-
Mark
SLEEP : Intervention with weighted blankets for children with attention deficit hyperactivity disorder (ADHD) and sleep problems: Study protocol for a randomised control trial
Larsson, Ingrid LU
; Aili, Katarina
; Nygren, Jens M.
LU
; Johansson, Pia
; Jarbin, Håkan
LU
and Svedberg, Petra
(2022)
In BMJ Open
12(1).
- Contribution to journal › Article
-
Mark
Predictive models for thromboembolic events in giant cell arteritis : A US veterans health administration population-based study
Michailidou, Despina ; Zhang, Tianyu ; Kuderer, Nicole M. ; Lyman, Gary H. ; Diamantopoulos, Andreas P. ; Stamatis, Pavlos LU
and Ng, Bernard
(2022)
In Frontiers in Immunology
13.
- Contribution to journal › Article
-
Mark
Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index
- Contribution to journal › Article
-
Mark
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis : Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses
- Contribution to journal › Article
-
Mark
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries
- Contribution to journal › Article
-
Mark
Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations
- Contribution to journal › Article
-
Mark
Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study
- Contribution to journal › Article
-
Mark
Incidence and prevalence of systemic sclerosis in Sweden, 2004–2015, a register-based study
- Contribution to journal › Article